Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators

June 17, 2020

Vyome releases positive phase II results for VB-1953

June 17, 2020

Positive data reported from phase II AFFIRM-35 study of ABY-035

June 17, 2020

Nflection Therapeutics divulges new MAP2K1 inhibitors

June 12, 2020

NFlection initiates phase IIa study of NFX-179 gel for cutaneous NF-1

June 10, 2020

Pfizer reports topline data from JADE TEEN trial of abrocitinib in adolescent atopic dermatitis

June 10, 2020

Lumosa initiates phase I/II study of LT-5001 for uremic pruritus in hemodialysis patients

June 8, 2020

Topline data announced from phase IIb study of gusacitinib in chronic hand eczema

June 3, 2020

AhR is a therapeutic target in psoriasis

May 29, 2020

First-in-human data for B-VEC in patients with recessive dystrophic epidermolysis bullosa

May 28, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...